Sex-differentiated germline genetic regulation of multiple myeloma risk and survival

Multiple myeloma (MM) is a hematologic malignancy in which males have approximately 1.5-fold higher incidence and mortality rates compared to females worldwide, with mortality rates reaching up to 1.7-fold higher in North America. However, the biological mechanisms underlying these observed sex differences remain poorly understood. Here, we investigate sex-differentiated germline genetic effects in MM and their impact on gene expression and survival outcomes. First, we compared sex-stratified MM genome-wide association study (GWAS) summary statistics from the UK Biobank (UKBB) to identify variants with sex-differential genetic effects contributing to MM risk. We then performed a transcriptome-wide association study (TWAS) using S-PrediXcan with GTEx v8 whole blood-derived gene expression prediction models to identify genes that may contribute to sex differential MM risk. Next, we further examined these candidate genes through sex-stratified germline cis-eQTL analyses in CD138⁺ malignant plasma cells from one of the largest MM patient datasets (MMRF CoMMpass study). Finally, we performed sex-stratified survival analyses using Cox proportional hazards models to evaluate the prognostic significance of candidate gene expression in MM. Our results show that sex-differentiated effects extend to genetically regulated tumor gene expression and identified genes, including CD70 , whose expression exhibits sex-dependent associations with MM survival outcomes. Overall, our findings support the presence of sex-differential genetic regulation in MM and that these differences may contribute to sex-dependent tumor gene expression and survival outcomes.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-11-21
DOI
https://doi.org/10.1186/s12885-026-17421-0
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sex-differentiated germline genetic regulation of multiple myeloma risk and survival

Barbara E. Stranger, Banabithi Bose, R. Stephanie Huang, Ajibola Opakunle
BMC Cancer
Multiple Myeloma Research and Treatments
article

Sex-differentiated germline genetic regulation of multiple myeloma risk and survival

Barbara E. Stranger, Banabithi Bose, R. Stephanie Huang, Ajibola Opakunle
article en

Abstract

Multiple myeloma (MM) is a hematologic malignancy in which males have approximately 1.5-fold higher incidence and mortality rates compared to females worldwide, with mortality rates reaching up to 1.7-fold higher in North America. However, the biological mechanisms underlying these observed sex differences remain poorly understood. Here, we investigate sex-differentiated germline genetic effects in MM and their impact on gene expression and survival outcomes. First, we compared sex-stratified MM genome-wide association study (GWAS) summary statistics from the UK Biobank (UKBB) to identify variants with sex-differential genetic effects contributing to MM risk. We then performed a transcriptome-wide association study (TWAS) using S-PrediXcan with GTEx v8 whole blood-derived gene expression prediction models to identify genes that may contribute to sex differential MM risk. Next, we further examined these candidate genes through sex-stratified germline cis-eQTL analyses in CD138⁺ malignant plasma cells from one of the largest MM patient datasets (MMRF CoMMpass study). Finally, we performed sex-stratified survival analyses using Cox proportional hazards models to evaluate the prognostic significance of candidate gene expression in MM. Our results show that sex-differentiated effects extend to genetically regulated tumor gene expression and identified genes, including CD70 , whose expression exhibits sex-dependent associations with MM survival outcomes. Overall, our findings support the presence of sex-differential genetic regulation in MM and that these differences may contribute to sex-dependent tumor gene expression and survival outcomes.

BMC Cancer
University of Minnesota (US), University of Minnesota Medical Center (US), University of Colorado Anschutz Medical Campus (US)
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Sex-differentiated germline genetic regulation of multiple myeloma risk and survival — Barbara E. Stranger, Banabithi Bose, et al. · BMC Cancer (2026) | TGRS Research Map | TGRS